STEK — Stemtech Corp

OTC · Consumer Discretionary · Distributors · CIK 1511820 ·
Last close
$0.00
Market Cap
$237.2K
52W High
$0.00
52W Low
$0.00
ADV30
57,387,232
Next earnings
Stemtech Corporation, a stem cell nutrition company, develops science-based products to help the body maintain healthy stem cell physiology in the Americas, Latin America, and Asia. The company's products enhance and support the work of the body's stem cells by releasing more stem cells, helping to circulate them in the blood, and migrate them into tissues, where they can perform their daily function of renewal for optimal health. It offers its products under the RCM System, stemrelease3, and Stemflo MigraStem brands; oral health care under the OraStem brand; and rapid renew stem cell peptide night cream under the Collect One brand name, as well as Cellect One shield hypochlorous acid skin care products. It sells products through independent distributors. Stemtech Corporation was founded in 2005 and is headquartered in Naples, Florida.

Quarterly Fundamentals

Revenues vs Net Income (last 4 Q)

Assets vs Liabilities (last 4 Q)

PeriodRevenuesGrossProfit OpIncomeNetIncomeAssets CashLiabilities
Mar 2026 462,957 353,653 -1,094,249 -1,252,880 3,253,268 256,149 11,331,353
Dec 2025 458,109 354,677 -863,937 -1,482,293 3,149,614 238,245 10,854,013
Sep 2025 852,300 682,483 -339,217 -809,406 3,755,801 255,416 10,301,779
Jun 2025 697,925 552,016 -300,988 -293,145 3,872,156 272,450 10,323,863

Cashflow TTM (yfinance, fills SEC gap)

Operating CF
$-198,958
Investing CF
$0
Financing CF
$358,417
CapEx
Dividends Paid
Buybacks
EPS Diluted TTM
$-0.02
As of
2026-06-28

Balance + Analyst (yfinance extras)

Retained Earnings
$-36,130,637
Inventory
$325,700
Receivables
$9,195
ST Investments
EBIT TTM
$-2,539,553
Pretax Income TTM
$-3,843,994
Interest Exp TTM
$1,304,441
Analysts

Yahoo Snapshot (yfinance, live)

Total Revenue
$2,471,291
EBITDA
$-2,430,899
Free Cash Flow
$877,793
Enterprise Value
$4,217,711
Total Cash
$256,149
Total Debt
$4,982,428
Shares Out
2,371,950,157
Trailing EPS
$-0.01
Book Value
$-0.00
ROE
ROA
-46.4%
Div Yield

Annual Trend (SEC EDGAR, last 4y)

Revenues vs Net Income (last 4y)

FY endRevenuesOpIncome NetIncomeAssetsLiabilities EquityOCF
Dec 2025 2,876,380 -2,709,047 -4,046,705 3,149,614 10,854,013 -483,583
Dec 2024 5,053,690 -2,386,427 -3,769,566 3,782,245 9,009,050 -601,198
Dec 2023 4,921,531 -4,224,548 -5,430,245 3,683,271 6,462,036 -2,036,012
Dec 2022 4,559,399 -5,023,380 -8,544,923 4,266,941 7,438,859 -1,216,948

Peers — same industry

TickerNameMarket CapLastDaily %
CWPE CW Petroleum Corp $294.0K $0.01
BHATF Blue Hat Interactive Entertainment Technology $102.2K $0.03
DTCKF DAVIS COMMODITIES Ltd $907.0K $1.06
AHRO Authentic Holdings, Inc. $1.24M $0.00
WTER ALKALINE WATER Co INC $1.28M $0.04

News headlines (Yahoo Finance, 1h cache)

Stemtech Corporation Declares July 2026 "Cellular Health Awareness Month"
2026-07-01 12:30 · Yahoo
Stemtech Corporation Issues 2025 Year-In-Review Letter Highlighting Corporate Strength, Global Expansion and Accelerating Market Opportunities
2026-06-23 12:30 · Yahoo
Stemtech Secures Inventory Funding
2026-04-07 12:30 · Yahoo
Stemtech Revolution 2026: A Bold New Era In Global Wellness
2026-03-18 12:30 · Yahoo
Stemtech Corporation Launches New Market Channel Biosciences Ecommerce
2026-02-26 13:30 · Yahoo
Stemtech Corporation Welcomes Dr. Zahooruddin To Life Sciences Advisory Board
2026-02-03 13:30 · Yahoo
Stemtech Corporation Appoints Dr. Lizette Leos, MD To Chief Scientific Officer (CSO)
2026-01-06 13:30 · Yahoo
Stemtech Corporation Announces Entry into China in a Joint Venture with Lightway Ventures
2025-12-02 13:30 · Yahoo
Stemtech Corporation - Stemtech Healthsciences India Pvt Ltd Announces Strategy for Market Entry
2025-10-27 12:30 · Yahoo
Stemtech Corporation Announces Entry Into India in a Joint Venture With Innoventure Dynamic LLP
2025-10-23 12:30 · Yahoo

Recent Insider Activity

No insider activity indexed for this ticker.